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Summary 
QUESTION UNDER STUDY: Surveys on tobacco consump-
tion represent an important decision aid for public 
health policy related to smoking. Although Switzerland's 
tobacco control policies and regulations are among the 
weakest, its reported smoking prevalence is among the 
lowest in Europe. However, there appears to be a dis-
crepancy between reported prevalence and aggregate 
data on national cigarette consumption. Our purpose 
was to closely look at this discrepancy and study its sig-
nificance. 
METHODS: Calculation of national aggregate tobacco 
consumption by Switzerland's resident population for 
the years 2012 to 2015 and comparison with reported 
consumption derived from survey results on smoking 
prevalence and intensity. Comparison with similar data 
for France for year 2014. Evaluation of several hypothe-
ses to explain the discrepancy between survey results 
and national aggregate consumption data. 
RESULTS: There was a large discrepancy of about 45% 
between reported smoking consumption implied by sur-
vey results and estimated actual consumption derived 
from aggregate data on sales. Whereas survey results 
suggest smoking prevalence in Switzerland to be around 
25% and rather stable during the period 2012 to 2015, 
true prevalence could be greater than 31%. 
CONCLUSION: The results of surveys aiming to estimate 
smoking prevalence and intensity in Switzerland may 
substantially suffer from underreporting, misreporting 
and sampling bias. Survey methodology needs to be ex-
amined to see whether such reporting discrepancy can 
be reduced. 
Key words: tobacco control; smoking prevalence; Swit-
zerland; prevention; public health policy 
Introduction 
Every year, more than 9000 persons die in Switzer-
land because of tobacco-related illnesses, which ac-
count for around 15% of all deaths in this country 
[1]. Furthermore, 300 000 people can be conserva-
tively estimated to suffer from a serious smoking-
related disease [2, 3]. (The US Surgeon General in 
his 2014 report [2] estimated that for one death at-
tributed to smoking, there were 30 people suffering 
from a serious smoking-related illness; we applied 
this proportion to the number of deaths caused by 
tobacco smoking in Switzerland.) This is likely to 
be an underestimate. Indeed, the Swiss Lung 
League [3] estimates that 400 000 persons suffer 
from chronic obstructive pulmonary disease 
(COPD) alone, a disease which is mostly caused by 
smoking (80 to 90% of persons with COPD are 
smokers).)  
According to official statistics, smoking prevalence 
in Switzerland is among the lowest in Europe (about 
25% [4–7], 28% is the average in Europe [8], 34.1% 
in France for age group 15–75 years [9]); adult daily 
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smoking prevalence appears to be lower in Switzer-
land than in most European countries, including all 
its neighbouring countries [10] (fig. 1).  
 
 
 
Figure 1: European countries ranked by adult daily smoking prevalence in 2013. Source: WHO Report on the Global Tobacco 
Epidemic, 2015 [10]. 
 
Addiction Monitoring in Switzerland (AMIS), the 
consortium of organisations mandated by the Swiss 
Federal Office of Public Health (FOPH) to establish 
prevalence statistics, states on its website [11] that 
“Available data on smoking prevalence in the coun-
tries neighbouring Switzerland (Germany, France, 
Italy and Austria) suggest proportions of smokers 
relatively similar to the Swiss figures or signifi-
cantly higher, particularly in France.” If smoking 
prevalence is taken as the indicator of success in to-
bacco control, Switzerland might appear to be doing 
as well as or better than its neighbours and better 
than most European countries. This observation was 
recently made by the Swiss Senate when rejecting a 
proposed tobacco product law: the senators consid-
ered current smoking prevention measures as effec-
tive and thus concluded there was no need to change 
them [12]. 
Tobacco is less regulated in Switzerland than in 
most other European countries. With respect to 
three key tobacco control measures – taxation, 
smoke-free policy in public places and advertising 
bans (corresponding respectively to articles 6, 8 and 
13 of the World Health Organization Framework 
Convention on Tobacco Control) – Switzerland 
trails behind most of the other countries included in 
the Tobacco Control Scale Europe 2013 [13]: it is 
last in terms of advertising bans and next to last in 
terms of affordability of tobacco products; its smok-
ing ban in public and work places is also among the 
weakest (figs 2–4). 
The present study was motivated by a crude com-
parison we had made between reported results of 
FOPH population-based surveys and aggregate 
measures of national tobacco consumption, which 
exhibited a substantial discrepancy, suggesting that 
official statistics might perhaps underestimate the 
actual prevalence of smoking in Switzerland. Could 
it be that legislators and other public health profes-
sional base their tobacco control policy decisions on 
smoking prevalence estimates that are more reassur-
ing than may be justified? 
It has been observed in other studies [14–16] that in 
surveys smokers tend to underreport (declare smok-
ing fewer daily cigarettes than they actually do) or 
misreport (declaring themselves as nonsmokers 
when they are irregular users or as non-daily users 
when they are regular smokers) their smoking sta-
tus. This is seen notably when total consumption es-
timated through survey data (hereafter called re-
ported consumption, following Kenneth Warner’s 
terminology [14]) is compared with consumption 
figures estimated from national aggregate data 
(hereafter called “actual consumption”, again 
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Warner’s terminology [14]): shortfalls of up to 33% 
have been observed, which means that reported con-
sumption accounted only for two thirds of actual 
consumption [14, 15]. 
Our aim was to perform a detailed comparison be-
tween reported consumption and actual consump-
tion in Switzerland in view of assessing the level of 
underreporting. Based on our finding, we will put 
forward possible reasons for this phenomenon. 
 
 
 
 
Figure 2: European countries ranked by index of affordability of tobacco products (vertical axis: number of 20-packs that can be 
purchased with 1% of GDP per capita). Source: WHO Report on the Global Tobacco Epidemic, 2015 [10]. 
 
 
 
Figure 3: European countries ranked by TCS score for smoke-free policies. Source: Tobacco Control Scale in Europe 2013 [13]. 
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Figure 4: European countries ranked by TCS score for advertising bans. Source: Tobacco Control Scale in Europe 2013 [13]. 
 
 
Materials and methods 
To evaluate cigarette consumption in a population, 
two methods are generally available: the first 
method is to obtain data by surveying a representa-
tive sample of the population, asking questions 
about individual smoking behaviour (hereafter “sur-
vey data”) – this is the usual way of calculating 
smoking prevalence officially reported by govern-
ments; the second approach uses aggregate data 
about volumes of sales of cigarettes, usually ob-
tained by governmental administrations in the con-
text of collecting excise taxes (hereafter “aggregate 
data”) [14–17]. Survey data offer the advantage of 
identifying group characteristics and factors linked 
to smoking, and provide more information about the 
consumer, but tend to suffer from reporting issues. 
Aggregate data (presented as total and/or per capita 
cigarette consumption) generally produce objective 
quantitative information about overall volumes. 
They are not affected by changing social attitudes 
towards smoking but lack information about con-
sumers. 
Actual consumption 
To be meaningful from a public health perspective, 
actual consumption of cigarettes by the resident 
population needs to be assessed. To estimate this, a 
starting point is legal domestic sales data (number 
of duty-paid cigarettes sold in the country). We ob-
tained these data from the Federal Customs Admin-
istration [18], which provided them with a dis-
claimer that “the sales figures do not correspond to 
the quantities consumed by the resident population. 
Indeed, the quantities of cigarettes sold strongly de-
pend on the evolution of purchases by cross-border 
commuters and foreign tourists, on contraband, of 
imports done in the context of touristic traffic or In-
ternet sales, on transition from manufactured ciga-
rettes to roll-you-own tobacco, and on provisions 
made by consumers when price increases are an-
nounced.” Thus, to obtain quantities consumed by 
the resident population, two adjustments are 
needed: 
– Adjustment 1: Aggregate data on sales of duty-
paid cigarettes in the country need to be adjusted 
to take into account cigarettes which are brought 
into the country via legal or illegal channels (in-
flows) and cigarettes which are sold but not con-
sumed in the country (outflows). Adjusting for 
inflows and outflows provides a measure of the 
cigarettes consumed in the country. 
– Adjustment 2: The number of the cigarettes con-
sumed in the country needs to be converted into 
the number of cigarettes consumed by residents. 
This is done by subtracting cigarettes smoked in 
Switzerland by tourists or other travellers while 
visiting the country and adding cigarettes con-
sumed by Swiss residents when they are abroad. 
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We will elaborate below how we applied these two 
adjustments to obtain an estimate of the number of 
cigarettes consumed by the Swiss resident popula-
tion. All our calculations are yearly and relate to 
years 2012-2015. We have all the data needed to 
perform our analysis for years 2013-2015 and have 
also included year 2012 by extrapolating some data, 
as will be shown below, to include the year covered 
by the most recent Swiss Health Survey (SHS) [19]. 
Comparison with France 
In the factsheet [20] published to present its pro-
posal for a new tobacco product law, the Federal Of-
fice of Public health compared tobacco regulations 
on advertising, promotion and sponsorship of Swit-
zerland with Germany and France. France is also 
pointed out as a country in which the proportions of 
smokers is “significantly higher” than in Switzer-
land [11]. 
Motivated by this reference to France, we decided 
to compare the Swiss results with corresponding 
French results. Fortunately, France is a neighbour-
ing country for which we could obtain all the data 
for a recent year (2014) necessary to make a full 
comparison. We could not get similarly complete 
data from other neighbouring countries. 
Roll-your-own cigarettes 
In addition to manufactured cigarettes, our aggre-
gate data also include roll-your-own (RYO) ciga-
rettes. National sales data on RYO are usually ex-
pressed in units of weight (tonnes). We have con-
verted these measures (for both Switzerland and 
France) into number of cigarettes, by assuming that 
one RYO cigarette contains 0.75 g of fine-cut to-
bacco, which corresponds to the median weight in 
Europe [21]. 
Reported prevalence and consumption 
Since 2011, the Swiss Federal Office of Public 
Health (FOPH) has been mandating a consortium of 
organisations, operating under the label Addiction 
Monitoring in Switzerland (AMIS), to carry out on 
its behalf representative monitoring of addiction 
and use of psychoactive substances, including to-
bacco and alcohol. Each year, around 10 000 per-
sons are interviewed through a telephone survey us-
ing predominantly home phones (with a mobile 
phone sample limited to 1000 persons). In the anal-
ysis below, we use the estimates contained in the 
AMIS report for the years 2012 to 2015 [4–7] for 
smoking prevalence and smoking intensity (number 
of daily cigarettes smoked on average by a smoker) 
for daily and occasional (non-daily) smokers, as 
well as for all smokers confounded. Using these es-
timates, we calculated reported consumption: 
Reported consumption (bn) = pop15+ * prevalence 
* dailycig * ndays / 109, with ndays = 366 for 2012 
and 365 for the other years  
In addition, we did the same calculation for year 
2012 using prevalence data obtained from the Swiss 
Health Survey 2012 [19] conducted by the Federal 
Office of Statistics every 5 years. 
For France, the data for reported prevalence are 
taken from the Baromètre santé 2014 survey [22]. 
However, as Baromètre santé 2014 only covers age 
group 15-75, we have extrapolated data from 
Baromètre santé 2010 [23] for the age group 76+ 
years. 
Data sources for legal domestic sales 
We obtained aggregate data on legal domestic sales 
for 2012 to 2015 from the Federal Customs Admin-
istration [18], which provided us with precise fig-
ures of the number of cigarettes and the quantity of 
fine cut tobacco (expressed in tons) sold on the do-
mestic market for each year of the period. 
For France, aggregate figures for legal domestic 
sales come from the data compiled by the Observa-
toire français des drogues et des toxicomanies 
(OFDT) [24]. OFDT obtained aggregate data from 
the French customs administration in charge of to-
bacco taxation, a source that is very similar to the 
one from which we obtained corresponding Swiss 
data. 
Inflows and outflows 
For adjustment 1, we used the estimates of in-
flows/outflows (for both Switzerland and France) 
from the KPMG Project Sun reports [25, 26]. 
KPMG is one of the Big Four accountancy firms of-
fering audit, assurance, tax, consulting and advisory 
services. In their Project Sun contracted by the four 
largest multinational tobacco firms, they studied 
and reported “on the estimated size and composition 
of the total cigarette market (including counterfeit 
and contraband products) […] for each of the 28 EU 
Member States, Norway and Switzerland.” Their re-
ports present data on total consumption of manufac-
tured cigarettes for each country included in the 
study. The amount of legal domestic sales was pro-
vided by the manufacturers themselves. To reach 
the total amount of consumed manufactured ciga-
rettes, outflows (cigarette bought in a country but 
consumed abroad) and inflows (both legal and ille-
gal) were estimated by KPMG using a method they 
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developed called the “empty pack survey”. Their 
methodology has been the subject of criticism, no-
tably because it “tends to overestimate illicit ciga-
rette levels particularly where cross-border shop-
ping is frequent (Austria, Finland, France)” [27]. 
However, these overestimates will not significantly 
affect our results and, if so, only conservatively (to-
wards reducing reporting discrepancy). 
It should be noted that KPMG’s estimates of inflows 
and outflows concern only manufactured cigarettes 
and do not relate to RYO. We assume that the in-
flows/outflows balance for RYO, which we have no 
means of estimating, is in any case negligible in our 
context and thus it is acceptable to ignore it in the 
calculations. This decision is conservative for our 
purpose, since because the inflows/outflows bal-
ance is positive for manufactured cigarettes, it is 
also likely to be positive for RYO, which would re-
sult in a larger total consumption in Switzerland. 
Finally, KPMG’s data do not cover year 2012. To 
extend our analysis to the year of the Swiss Health 
Survey, we have extrapolated KPMG 2013–2015 
inflows/outflows results to 2012 by using their av-
erage. It is believed that the small inaccuracy thus 
introduced is unlikely to substantially alter our con-
clusions. 
Balance of tourism 
The tool we have at our disposal for adjustment 2 is 
the balance of tourism published in Switzerland by 
the Federal Office of Statistics [28] (and in France 
by the Institut national de la statistique et des études 
économiques: INSEE [29]). The balance of tourism 
is the difference between the money nonresidents 
spend in the country when visiting it and the money 
spent by residents when they visit other countries. 
Our assumption is that, at equal budget, Swiss resi-
dents traveling abroad will buy the same number of 
cigarettes outside the country as nonresidents visit-
ing Switzerland, so that the net resulting consump-
tion will be zero if the balance of tourism is zero. 
This is in fact conservative for our purpose. Indeed, 
using data from the 2014 results of the KPMG re-
port [25], yearly per capita consumption of manu-
factured cigarettes is higher among Swiss people 
(1279) than the European average (1070), and the 
price of cigarettes is higher in Switzerland than in 
most European countries. Thus, Swiss smokers 
travelling abroad will be more likely to buy ciga-
rettes in the destination country (or in duty-free 
shops), than tourists visiting Switzerland to buy do-
mestic cigarettes. We thus assumed (conserva-
tively) that only the balance of tourism needs to be 
considered to apply adjustment 2. We assumed 
(again conservatively) that a third of tourists smoke 
and spend on average 5% of their budget on ciga-
rettes. 
Results 
Actual consumption: number of cigarettes 
smoked by Swiss residents, 2012–2015 
The results leading to the calculation of actual con-
sumption of cigarettes by Swiss residents during the 
period 2012 to 2015 are shown in table 1. 
Domestic legal sales data obtained from the Swiss 
Federal Customs Administration (FCA) indicates 
that the sales of manufactured cigarettes steadily de-
creased over the period, ranging from 11.43 billion 
(bn: 109) in 2012 to 9.91 bn in 2015 [18]. 
Adjustment 1 
The KPMG reports [25, 26] provide data for the 
years 2013 to 2015 indicating that the number of 
manufactured cigarettes that were brought into the 
country, either legally or illegally via contraband or 
as counterfeit cigarettes (inflows) ranged from 0.92 
bn (in 2014) to 1.36 bn (in 2015), while the number 
of manufactured cigarettes sold in Switzerland 
which were consumed outside the country (out-
flows) ranged from 0.28 bn (in 2015) to 0.47 bn 
(2014). As explained above, inflows/outflows data 
for 2012 were obtained by extrapolation. The in-
flows/outflows balance was positive throughout the 
period 2013 to 2015, adding from 0.45 bn units (in 
2014) to 1.08 bn units (in 2015) to legal domestic 
sales, while remaining below 10% of the total num-
ber of manufactured cigarettes consumed in Swit-
zerland, which ranged from 12.26 units in 2012 to 
10.70 units in 2014. It should be noted that the de-
crease in legal domestic sales of cigarettes observed 
in 2015 was partly compensated by an increase of 
legal nondomestic consumption (from 0.68 bn in 
2014 to 1.07 bn in 2015 – not shown in table 1) [26]. 
KPMG observes that duty-free inflows account for 
a quarter of the cigarettes legally entering the coun-
try, a proportion higher than other EU countries, no-
tably since 2011, when travellers entering Switzer-
land were entitled to a duty-free allowance. This 
phenomenon was accentuated in 2015 with the 
strong appreciation of the Swiss franc at the begin-
ning of the year, which also reduced outflows [26]. 
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Table 1: Total cigarette consumption in Switzerland for the years 2012 to 2015.  
Category 2012 2013 2014 2015 
Legal domestic sales* 11.43 10.81 10.25 9.91 
Outflows† ˗0.37 ˗0.35 ˗0.47 ˗0.28 
Inflows† 1.20 1.32 0.92 1.36 
Net inflows 0.83 0.97 0.45 1.08 
Total manufactured cigarettes 12.26 11.78 10.70 10.99 
Roll-your-own cigarettes* 0.77 0.76 0.91 0.91 
Total cigarettes consumed in Switzerland 13.03 12.53 11.60 11.91 
Tourism balance adjustment‡ -0.04 -0.03 -0.04 -0.01 
Total cigarettes consumed by Swiss residents 12.99 12.50 11.56 11.90 
Sources: 
* Federal Customs Administration [18] 
† KPMG Sun Report 2014 and 2015 [25, 26] 
‡ calculated based on Federal Office of Statistics data [28] – see text 
 
 
Roll-your-own cigarettes 
Conversion of the amounts of fine-cut tobacco sold 
in the period 2012 to 2015 [18] adds between 0.76 
bn cigarettes (in 2013) to 0.91 bn cigarettes (in 2014 
and 2015). Consequently, the total number of ciga-
rettes (manufactured and RYO) consumed in Swit-
zerland was 13.03 bn units in 2012, decreased to 
reach 11.60 bn units in 2014, and slightly increased 
again in 2015 to 11.91 bn units. 
Adjustment 2 
Switzerland’s balance of tourism was positive 
throughout all four years (maximum CHF 854 mil-
lion in 2014, minimum CHF 323 million in 2015). 
The related excess of cigarettes bought on the do-
mestic market by visitors led to a small adjustment 
ranging between 0.01 bn units (2015) and 0.04 bn 
units (2014), which were subtracted as these ciga-
rettes were not consumed by Swiss residents. 
The final estimate of the number of cigarettes 
smoked by the Swiss resident population was above 
11.5 bn units across all four years, ranging from 
11.56 bn units in 2014 to 12.99 bn units in 2012 (see 
table 1). 
Reported consumption: cigarette consumption 
implied by survey results 
The AMIS results for the period 2012 to 2015 (table 
2) show overall prevalence figures that have re-
mained relatively stable over the period, ranging 
from of 24.9% (2014) to 25.9% (2012). The average 
number of daily cigarettes per smoker has slightly 
decreased, from 10.3 in 2012 and 10.5 in 2013, 
down to 9.9 in 2014 and 2015. 
When applied to the resident population aged 15+ 
years [30], these figures translate into reported con-
sumption which, again, is rather stable over the pe-
riod, ranging from a minimum of 6.31 bn units (in 
2014) to a maximum of 6.65 bn units (in 2012). For 
all years, the shortfall between reported consump-
tion and estimated actual consumption is consist-
ently high, exceeding 5 bn cigarettes. Over the en-
tire period, reported consumption only accounts for 
between 50 and 55% of estimated actual consump-
tion. 
For the year 2012, we also extrapolated total con-
sumption using the prevalence estimate taken from 
the Swiss Health Survey 2012 [19], which was 
slightly higher than its AMIS counterpart (28.2 vs 
25.9%), whereas the average of daily cigarettes per 
smoker was slightly lower (10.1 vs 10.3). Although 
a bit smaller, the discrepancy between SHS reported 
consumption and estimated actual consumption re-
mains large (5.85 bn cigarettes): SHS reported con-
sumption accounts for only 55.0% of estimated ac-
tual consumption.
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Table 2: Swiss Health Survey (SHS) and Addiction Monitoring in Switzerland (AMIS) reported cigarette consumption com-
pared with estimated actual consumption for the years 2012 to 2014.  
 
SHS AMIS 
2012 2012 2013 2014 2015 
Reported prevalence* 28.2% 25.9% 25.0% 24.9% 25.0% 
Average daily cigarettes per smoker† 10.1 10.3 10.5 9.9 9.9 
Population aged 15+ years‡ 6 838 457 6 838 457 6 927 354 7 012 685 7 090 334 
Reported consumption (bn cigarettes)§ 7.14 6.65 6.61 6.31 6.41 
Estimated actual consumption (bn cigarettes)⁋ 12.99 12.99 12.50 11.56 11.90 
Discrepancy between reported consumption and actual 
consumption (bn cigarettes)§ 
5.85 6.34 5.90 5.26 5.48 
Relative discrepancy of reported consumption§ 45.0% 48.8% 47.2% 45.5% 46.1% 
Actual number of cigarettes per year per capita§ 1900 1900 1805 1649 1678 
bn = billion (109) 
Sources: 
* SHS 2012 [19] and AMIS 2012, 2013, 2014 and 2015 [4–7] 
† Calculated from SHS and AMIS data (same source as *) 
‡ Federal Office of Statistics [30] 
§ Calculated – see text 
⁋ See table 1 
 
Comparing Switzerland with France 
To compare Swiss results with corresponding 
French results (Table 3), we took data from 
Baromètre santé 2014 [22], adjusted with data from 
Baromètre santé 2010 [23] for ages classes 76+ 
years to make them comparable with AMIS results. 
In 2014, the French reported smoking prevalence 
was 31.0%. This prevalence, together with an aver-
age of 11.3 cigarettes consumed daily, applied to the 
French metropolitan population on 1 January 2015 
[31], result in a reported consumption of 66.38 bn 
cigarettes for year 2014. Legal domestic sales came 
from OFDT [24] and inflows/outflows were ob-
tained from KPMG’s publication for the year 2014 
[25], totalling 60.45 bn units for manufactured cig-
arettes. The number of RYO cigarettes (11.26 bn) 
was calculated from the amount of fine-cut tobacco 
sold in 2014 [24], again assuming 0.75 g per ciga-
rette, resulting in a total of 71.72 bn cigarettes con-
sumed in metropolitan France in 2014, excluding 
Corsica. Applying a correction factor proportional 
to the population for the omission of Corsica in 
OFDT and KPMG data, the total becomes 72.08 bn 
cigarettes. As a last step, we applied adjustment 2 
based on the balance of tourism. The French balance 
of tourism was approximately a positive EUR 10 bn 
in 2014 [29]. The excess of cigarettes consumed by 
tourists, which was not compensated by cigarettes 
consumed by French residents when visiting other 
countries, was thus estimated to be 0.49 bn units. 
Subtracting this last number left 71.59 bn cigarettes 
consumed by the French resident population in 2014 
(see table 1). 
In 2014, reported smoking prevalence was substan-
tially lower in Switzerland than in France (24.9% vs 
31.0%) and Swiss smokers reported an average con-
sumption of fewer daily cigarettes than their French 
counterparts (9.9 vs 11.3). However, per capita con-
sumption of cigarettes was 20% higher in Switzer-
land than in France (1649 vs 1371). (Per capita con-
sumption = average of consumed cigarettes per year 
per resident aged 15+, regardless of smoking sta-
tus.) One element of an answer to this apparent con-
tradiction may be provided by looking at the dis-
crepancy between reported consumption and actual 
consumption, which was much higher for Switzer-
land than for France (45.5% vs 7.3%). 
 
  
Swiss Medical Weekly · PDF of the online version · www.smw.ch   Page 9 of 14 
Published under the copyright license "Attribution - Non-Commercial - No Derivatives 4.0".  
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html. 
Table 3: Comparison of Switzerland and France with respect to relevant cigarette smoking variables for the year 2014. 
 Switzerland France 
Reported prevalence* 24.9% 31.0% 
Average daily cigarettes per smoker* 9.9 11.3 
Population aged 15+ years† 7 012 685 52 197 423 
Reported consumption (bn cigarettes)‡ 6.31 66.38 
Estimated actual consumption (bn cigarettes)§ 11.57 71.59 
Relative discrepancy of reported consumption compared to actual consumption‡ 45.5% 7.3% 
Actual number of cigarettes / year per capita‡ 1649 1371 
bn = billion (109) 
Sources:  
For Switzerland, see table 2.  
For France: 
* Calculated – see text - from Baromètre santé 2014 [22] and Baromètre santé 2010 [23] 
† Institut national de la statistique et des études économiques (INSEE) [31] 
‡ Calculated – see text 
§ Calculated based on data from Observatoire français des drogues et des toxicomanies (OFDT) [24], KPMG Sun Project report 2014 [25] and 
INSEE [29] – see text 
 
Discussion 
The discrepancy between reported consumption and 
our estimate of actual consumption appears to be a 
phenomenon that has remained large and relatively 
constant over the period under study, ranging be-
tween 45 and 50% in the years 2012 to 2015. Alt-
hough this paper has concentrated on the AMIS sur-
vey, the SHS survey does not appear to be immune 
from the phenomenon, although it is slightly less 
pronounced (SHS reporting discrepancy: 45.1%; 
AMIS reporting discrepancy in 2012: 48.8%). 
The reporting discrepancy might be the result of one 
or several of the following anomalies: 
– Reported consumption is larger than our calcula-
tion indicates. 
– Actual consumption is lower than aggregate data 
indicate. 
– Actual smoking intensity (daily cigarettes) is 
higher than reported by surveys. 
– Actual prevalence is higher than reported by sur-
veys. 
Explanation 1: Reported consumption is larger 
than our calculation indicates 
The way we derived total consumption from the 
AMIS estimates of prevalence and smoking inten-
sity was rather straightforward and can be easily 
verified. As a matter of verification, the amount we 
described for 2014 (6.31 bn cigarettes) for reported 
consumption is just slightly larger, that is, on the 
conservative side, than the reported consumption 
calculated by the Federal Office of Public Health of 
6.137 bn cigarettes [32]. 
The reported consumption refers only to age group 
15+ years and does not take into account consump-
tion by children below the age of 15. Although 
smoking in children aged less than 15 years is a 
highly preoccupying problem from a public health 
point of view, this part of total cigarette consump-
tion in the general population is very small. Assum-
ing plausibly that 5% of the children aged 12–14 
smoke on average 5 cigarettes per day, their total 
consumption would amount to 0.02 bn cigarettes. 
(Taking 2012 as reference year (year with maxi-
mum 12–14 population of the study period), (249 
945 persons aged 12–14)*0.05*5*366/109 = 0.023 
bn cigarettes / year.) If this number is added to the 
reported consumption estimated by FOPH, the total 
is still under the 6.31 bn cigarettes shown in table 2 
for 2014. It should be noted also that this issue does 
not affect the comparison with France, since French 
data also relate to age group 15+. 
Two other issues also arise in the calculation of re-
ported consumption. People who declared them-
selves as smokers may have subsequently quit 
smoking during the same year, therefore consuming 
cigarettes for fewer than 365 days, whereas our cal-
culation assumes that all smokers keep smoking the 
average number of daily cigarettes for the whole 
year, thus overestimating actual consumption. On 
the other hand, especially among young respond-
ents, some nonsmokers at the time of the interview 
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may have started smoking later in the year, thus con-
suming cigarettes that are not taken into account in 
our measure of reported consumption. However, 
consistently with previous findings by Hatziandreu 
et al. [15], we can assume that these two effects are 
small and, as the population of smokers has re-
mained relatively stable in 2014 compared with pre-
vious years, that they cancel each other out. 
We therefore reject explanation 1. 
Explanation 2: Actual consumption is lower 
than aggregate data indicate 
The possibility that actual consumption was lower 
than our estimates cannot be excluded. Data that 
could be questioned are the inflows and outflows 
taken from the KPMG reports [25, 26], which indi-
cate a positive balance. However, this balance is rel-
atively small (always less than 10% of the domestic 
consumption of manufactured cigarettes) and, even 
assuming the unlikely possibility that it is zero, this 
would not remove the discrepancy between reported 
consumption and actual consumption: there would 
still remain a discrepancy of at least 4 bn cigarettes 
for each year of the period. 
Cigarettes bought in Switzerland and on which ex-
cise taxes were fully levied were very unlikely to 
have been massively exported to other countries, as 
they were similarly or more expensive than ciga-
rettes in neighbouring countries at the time, as is 
shown in table 4. 
 
Table 4: Weighted average price for a pack of 20 cigarettes in Switzerland and neighbouring countries at end of 2014 and 
2015.  
 Average price of a pack of 20 cigarettes (euros) 
 Switzerland France Germany Austria Italy 
End of 2014 6.64 6.74 5.13 4.33 4.52 
End of 2015 7.12 6.75 5.34 4.48 4.66 
Source: KPMG Sun Project reports [25, 26]. 
 
The KPMG reports [25, 26] found that inflows of 
legally imported cigarettes originate mostly from 
Germany and Italy, whereas the legal flow from 
France (between 0.04 bn and 0.12 bn cigarettes) is 
reflected by the high volumes of tourists and com-
muters consuming French-origin packs when in 
Switzerland. This is something we have taken into 
account with our balance of tourism adjustment. 
Illegal inflows (mostly contraband) are estimated by 
the KPMG reports [25, 26] to be 3.7%, 2.2% and 
2.6% of the total consumption of manufactured cig-
arettes in 2013, 2014 and 2015, respectively, 
whereas the Federal Customs Administration esti-
mates that it is “well below 5%” [33]. Both agree 
that this proportion is small. Even allowing for pos-
sible inaccuracies, the contribution of inflows and 
outflows, and their balance, would remain within a 
few percent of total consumption and therefore can-
not explain the discrepancy. 
Finally, one possibility could consist in smokers not 
consuming all the cigarettes they buy and throwing 
away some of them. Although we do not have sci-
entific data on this subject, we find it unlikely that 
smokers would throw away cigarettes in any signif-
icant way, given their price. If the phenomenon ex-
ists, it must be very rare: KPMG has called its meth-
odology “empty pack survey” [25, 26] probably be-
cause the cigarette packs they collect in the streets 
are indeed empty. We therefore assume such a phe-
nomenon is not of sufficient scale to alter our results 
in any significant way. 
We therefore reject explanation 2. 
Explanation 3: Actual smoking intensity is 
higher than reported by surveys 
The AMIS survey results for 2014 indicate that 
smoking intensity was lower in Switzerland than in 
France (see table 3): on average, Swiss smokers de-
clared consuming 9.9 cigarettes per day, and their 
French counterparts reported 11.3 cigarettes daily. 
The proportion of nondaily consumers among 
smokers was much larger in Switzerland (31%) than 
in France (17%). 
It is known that smokers tend to underreport the 
quantity of cigarettes they smoke, for instance by 
32% as described in a study from the USA [11]. 
While this phenomenon could be involved here, it is 
still intriguing why it would particularly affect 
Swiss survey respondents, while the French 
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Baromètre santé 2014 survey seems to be almost 
immune to such underreporting. Assuming that 
French smokers only underreported the daily num-
ber of cigarettes they smoke, this would be at most 
by 7.3%: the true number of cigarettes they smoked 
on average per day in 2014 would not exceed 12.1 
cigarettes. As Europeans, Swiss and French smok-
ers can be presumed to be culturally closer to each 
other than they are to smokers in the USA, one 
could thus assume that underreporting of smoking 
intensity by Swiss residents would be closer to that 
of French residents than in the USA. Thus, the 
Swiss underreporting of daily cigarettes is plausibly 
between 7.3% (like France) and the upper limit of 
32% (like the USA). 
 
Table 5: Two scenarios of smoking intensity in Switzerland. 
Scenario 1: Daily cigarettes same as maximum for France after correction for underreporting; Scenario 2: Prevalence of 
smoking same as France. The fixed variable for each scenario is shown in bold type. 
 AMIS Scenario 1 Scenario 2 
Reported prevalence (AMIS 2014) 24.9% 24.9% 24.9% 
Daily cigarettes 9.9 12.1 14.6 
(Implied actual underreporting in scenario) – 18.4% 32.2% 
Reported consumption 
(bn cigarettes) 
6.31 7.74 9.31 
Actual consumption in 2014 
(bn cigarettes) 
11.57 11.57 11.57 
Reporting discrepancy: gap between reported and actual consumption as a percent-
age of actual consumption 
45.5% 33.1% 19.6% 
Implied prevalence 45.7% 37.2% 31.0% 
Prevalence discrepancy: gap between reported and implied prevalence 20.8% 12.3% 6.1% 
AMIS = Addiction Monitoring in Switzerland; bn = billion (109) 
 
To assess the sensitivity to smoking intensity, we 
performed the calculations comparing AMIS preva-
lence and smoking intensity values with two scenar-
ios (shown in table 5), with 2014 results as refer-
ence, to make it possible to compare with corre-
sponding French results: 
– Scenario 1 assumes that smoking intensity was 
the same in Switzerland as the average of number 
of daily cigarettes that could be envisaged in 
France if there was no reporting discrepancy in 
this country (average of 12.1 daily cigarettes per 
smoker; see above). This would explain the con-
sumption of 7.74 bn cigarettes, with a reporting 
discrepancy of 33.1% to aggregate data on total 
amount smoked per year in Switzerland. Alterna-
tively, with such an average number of daily cig-
arettes, actual consumption could only be 
achieved with a smoking prevalence of 37.2% (in 
which case reported prevalence would underesti-
mate actual prevalence by 12.3 percentage 
points). 
– Scenario 2 shows that Swiss smokers would have 
to smoke an average of 14.6 daily cigarettes in 
order to reach the same reported prevalence as 
France (31.0%) while reaching actual consump-
tion of 11.57 bn cigarettes. It may be noted that 
assuming such an average of 14.6 daily cigarettes 
with AMIS reported prevalence of 24.9% would 
still leave a reporting discrepancy of 19.6%. Such 
a scenario assumes that the AMIS results for 
2014 underreported smoking intensity (cigarettes 
per day) by 32.2%, which is the level indicated 
by Farrelly et al. [12] for the United States. 
The two scenarios assume that Swiss smokers con-
sume as many or more cigarettes daily than their 
French counterparts, an assumption that is not 
highly plausible and would need to be verified. For 
instance, in 2014, the level of unemployment was 
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three times higher in France than in Switzerland [34, 
35]. People with a low socioeconomic status or who 
are unemployed tend to smoke more than the rest of 
the population, both in terms of prevalence and 
number of daily cigarettes [36–38]. With more than 
10% of its active population without a job [39], 
France had in 2014 a large pool of heavy smokers 
with no similar counterpart in Switzerland [40]. 
We further observe that in these two scenarios, the 
prevalence required to consume 11.56 bn cigarettes 
is above 31%, which is at least 6% higher than 
AMIS reported prevalence. 
Finally, we have calculated that if the discrepancy 
came only from underreporting, this would imply 
that daily smokers in Switzerland smoke on average 
25 cigarettes per day, 10 more than their French 
counterparts under the same assumption. We see no 
valid explanation for such a huge difference. 
We therefore conclude that explanation 3 can be ac-
cepted, but is not sufficient to fully explain the dis-
crepancy even when adjusted for underreporting of 
smoking intensity. 
Explanation 4: Actual prevalence is higher than 
reported by surveys 
Having been unable to fully elicit the discrepancy 
with the previous explanations, we are left with the 
explanation that actual prevalence in Switzerland is 
higher than what is being reported. What could be 
the cause of such differences? We see two possibil-
ities: 
– Misreporting. It is known that in surveys with 
questions related to socially undesirable behav-
iours, there is a risk that respondents provide an-
swers which understate the reality of their behav-
iour or even hide it [14]. Although this phenom-
enon is more marked with self-reporting of the 
number of daily cigarettes (underreporting), it is 
likely to also affect self-reporting of smoking sta-
tus (misreporting). One possible further cause of 
under- or misreporting would be with respond-
ents who use cannabis. Dual cigarette/cannabis 
users might consider themselves primarily as 
cannabis users or might be reluctant to report 
their smoking status as it is associated with an ac-
tivity which is illegal in Switzerland. Four out of 
five young cannabis-only users (3.4% of adoles-
cents) who mull frequently (i.e., add tobacco to 
cannabis for its consumption) could also be con-
sidered as cigarette smokers [41]. However, prev-
alence in Switzerland of cannabis use remains 
relatively small compared with tobacco (3% use 
during the last 30 days [4]) and is insufficient to 
explain the reporting discrepancy. Another possi-
ble aggravating factor might be a priming effect 
of questions related to alcohol, which precede 
questions on tobacco in both the AMIS and SHS 
questionnaires, since alcohol consumption is 
known to be associated with a high rate of report-
ing discrepancy [42]. 
– Sampling bias. Heavy tobacco users, who often 
are also heavy alcohol drinkers, might be reluc-
tant to accept being included in AMIS, a survey 
about addictions, as they might have concerns 
about being stigmatised by the questions. Again, 
cannabis users might be more likely to refuse to 
participate in the survey owing to the illegal char-
acter of their consumption. Furthermore, Swiss 
residents randomly designated to participate in 
AMIS but who did not possess a registered fixed 
phone (many young professionals) could have 
more easily dropped out of the survey sample. 
We therefore conclude that explanations 3 and 4 to-
gether provide the plausible answer. The large dis-
crepancy between reported consumption and actual 
consumption is most likely the combined effect of 
underreporting the intensity of smoking (number of 
daily cigarettes), misreporting the smoking status 
and sampling bias. 
Our analysis therefore suggests that Swiss reported 
statistics underestimate true prevalence. Compari-
sons with France further suggests that the level of 
underestimation could be at least by 6 percentage 
points, i.e., true prevalence might be 31% or more. 
Conclusion 
Misreporting prevalence and underreporting smok-
ing intensity in surveys have been documented in 
the literature, but the level of discrepancy is gener-
ally smaller than the discrepancy observed in the 
Swiss surveys on smoking, where reported con-
sumption from AMIS and SHS survey results ex-
plain only about 55% of actual consumption of cig-
arettes. 
Swiss data on tobacco smoking offer an illustration 
of Kenneth Warner’s observation that “analyses of 
the surveys not only understate the level of smoking 
at any point in time, they also present the public 
with an erroneous view of behavioural change, mix-
ing under that label true changes in smoking behav-
iour with increases in underreporting” [14]. For in-
stance, a decrease of self-reported smoking preva-
lence would not necessarily mean a corresponding 
decrease in actual smoking prevalence, but could re-
flect a behavioural change of respondents who be-
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come more reluctant to declare themselves as smok-
ers and who are more prone to claim that they smoke 
fewer cigarettes than they actually do [15]. Thus, 
prevalence results may not be comparable across 
years and their public health pertinence may thus be 
reduced. 
Our finding suggests that current official data about 
smoking prevalence in Switzerland may underesti-
mate actual prevalence by at least 6 percentage 
points. Identifying the specific causes for the report-
ing discrepancy described in the present paper could 
help in finding ways to improve official data quality 
through adaptation of survey methodology. Swiss 
public health and political decision makers need re-
liable indicators of smoking prevalence, notably if 
Switzerland wants to monitor its progress towards 
achieving the voluntary global target of a 30% rela-
tive reduction in prevalence of current tobacco use 
in persons aged 15 or older by year 2025, a key tar-
get of the WHO Global Action Plan for the Preven-
tion and Control of Non-Communicable Diseases 
2013-2020 [43], of which Switzerland is a signa-
tory. 
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